Postural orthostatic tachycardia syndrome: Difference between revisions
m (→Overview) |
|||
Line 13: | Line 13: | ||
<br /> | <br /> | ||
==[[Postural orthostatic tachycardia syndrome pathophysiology|Pathophysiology]]== | ==[[Postural orthostatic tachycardia syndrome pathophysiology|Pathophysiology]]== | ||
The pathophysiology is poorly understood and multifactorial. There are many reported findings across patients with POTS | The pathophysiology is poorly understood and multifactorial. There are many reported findings across patients with POTS, which are interlinked and present in a variety of combinations, making it difficult to pinpoint one as primary and thereby causative. Evidence suggests that the etiology involves: | ||
Distal denervation with preservation of cardiac innervation | * Distal denervation with preservation of cardiac innervation. Studies have shown reduced response to stimulation in the lower limbs in patients with POTS. This is thought to be due to a neuropathy arising post infection, however there is also evidence of autoantibodies against the ganglionic acetylcholine receptor, lending support for an autoimmune origin of the disease. | ||
* Hypovolemia or possible increased baroreceptor sensitivity. The most significant finding to lead to this theory is the symptomatic relief experienced by patients after infusion of saline, along with findings that suggest a predisposition to volume constriction in these patients. Conversely, constant and prolonged sympathetic activation could cause a mild reduction in circulating volume. | |||
Hypovolemia or possible increased baroreceptor sensitivity | * abnormal venous function causing decreased preload on standing. Evidence of venous pooling and therefore reduced venous return has been reported in some studies, along with the reduction of symptoms with the use of compression trousers. This could be due to the denervation of the distal limbs or the increased release of vasodilators. | ||
* cardiovasclar deconditioning | |||
abnormal | * hyperadrenergic state (increase in sympathetic activity) | ||
* genetic factors<br /> | |||
cardiovasclar deconditioning | |||
hyperadrenergic state (increase in sympathetic activity) | |||
genetic factors<br /> | |||
==[[Postural orthostatic tachycardia syndrome differential diagnosis|Differentiating POTS from Other Disorders]]== | ==[[Postural orthostatic tachycardia syndrome differential diagnosis|Differentiating POTS from Other Disorders]]== | ||
<br /> | <br /> |
Revision as of 19:15, 31 May 2020
Postural orthostatic tachycardia syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postural orthostatic tachycardia syndrome On the Web |
American Roentgen Ray Society Images of Postural orthostatic tachycardia syndrome |
Directions to Hospitals Treating Postural orthostatic tachycardia syndrome |
Risk calculators and risk factors for Postural orthostatic tachycardia syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
For patient information click here
Synonyms and Keywords: postural tachycardia syndrome, POTS
Overview
Postural orthostatic tachycardia syndrome is a poorly understood autonomic disturbance, which manifests as a change in HR>30BPM upon the patient standing erect from supine or a head-up tilt without underlying orthostatic hypotension. Sympathetic hyperstimulation secondary to a fall in vascular tone and cerebral hypoperfusion leads to transient symptoms such as inappropriate sinus tachycardia, chronic fatigue and dizziness. Many patients also report non specific symptoms such as GI disturbances and sleep disturbances. This incapacitating syndrome has no known etiology, with theories listing post infectious, autoimmune, cardiac deconditioning and emotional states as possible factors. Antinuclear antibodies along with elevated ganglionic, adrenergic, and muscarinic acetylcholine receptor antibodies have all been reported. Diagnosis involves eliminating all primary cardiac, endocrine, neuropathic and psychiatric causes of postural tachycardia. Treatment is multimodal and consists of patient education, volume replenishment, physical countermaneuvers (graded stockings) and pharmacological therapy.
Historical Perspective
Pathophysiology
The pathophysiology is poorly understood and multifactorial. There are many reported findings across patients with POTS, which are interlinked and present in a variety of combinations, making it difficult to pinpoint one as primary and thereby causative. Evidence suggests that the etiology involves:
- Distal denervation with preservation of cardiac innervation. Studies have shown reduced response to stimulation in the lower limbs in patients with POTS. This is thought to be due to a neuropathy arising post infection, however there is also evidence of autoantibodies against the ganglionic acetylcholine receptor, lending support for an autoimmune origin of the disease.
- Hypovolemia or possible increased baroreceptor sensitivity. The most significant finding to lead to this theory is the symptomatic relief experienced by patients after infusion of saline, along with findings that suggest a predisposition to volume constriction in these patients. Conversely, constant and prolonged sympathetic activation could cause a mild reduction in circulating volume.
- abnormal venous function causing decreased preload on standing. Evidence of venous pooling and therefore reduced venous return has been reported in some studies, along with the reduction of symptoms with the use of compression trousers. This could be due to the denervation of the distal limbs or the increased release of vasodilators.
- cardiovasclar deconditioning
- hyperadrenergic state (increase in sympathetic activity)
- genetic factors
Differentiating POTS from Other Disorders
Epidemiology and Demographics
POTS is believed to be the most prevalent type of orthostatic intolerance. One study approximates the prevalence to be 500,000 americans. It is also commonly seen in younger patients (<45 years) who present to autonomic dysfunction clinics. Women are more likely to suffer from this disorder, with the ratio between genders being 4-5:1. The cause of this is unknown as yet. There is no racial predilection to this disorder.
Risk Factors
Natural History, Complications and Prognosis
Most patients present young, and prognosis is generally favourable.
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | Echocardiography | Other Diagnostic Studies
Treatment
ACC/AHA/ESC Treatment Guidelines | Medical Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies